» Articles » PMID: 30488612

GWAS and Network Analysis of Co-occurring Nicotine and Alcohol Dependence Identifies Significantly Associated Alleles and Network

Overview
Date 2018 Nov 30
PMID 30488612
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol dependence (AD) and nicotine dependence (ND) co-occur frequently (AD+ND). We integrated SNP-based, gene-based, and protein-protein interaction network analyses to identify shared risk genes or gene subnetworks for AD+ND in African Americans (AAs, N = 2,094) and European Americans (EAs, N = 1,207). The DSM-IV criterion counts for AD and ND were modeled as two dependent variables in a multivariate linear mixed model, and analyzed separately for the two populations. The most significant SNP was rs6579845 in EAs (p < 1.29 × 10 ) in GM2A, which encodes GM2 ganglioside activator, and is a cis-expression quantitative locus that affects GM2A expression in blood and brain tissues. However, this SNP was not replicated in our another small sample (N = 678). We identified a subnetwork of 24 genes that contributed to the AD+ND criterion counts. In the gene-set analysis for the subnetwork in an independent sample, the Study of Addiction: Genetics and Environment project (predominately EAs), these 24 genes as a set differed in AD+ND versus control subjects in EAs (p = .041). Functional enrichment analysis for this subnetwork revealed that the gene enrichment involved primarily nerve growth factor pathways, and cocaine and amphetamine addiction. In conclusion, we identified a genome-wide significant variant at GM2A and a gene subnetwork underlying the genetic trait of shared AD+ND. These results increase our understanding of the shared (pleiotropic) genetic risk that underlies AD+ND.

Citing Articles

Genome-wide meta-analyses of cross substance use disorders in European, African, and Latino ancestry populations.

Lai D, Zhang M, Green N, Abreu M, Schwantes-An T, Parker C Res Sq. 2024; .

PMID: 39070649 PMC: 11275984. DOI: 10.21203/rs.3.rs-3955955/v1.


Identification of biomarkers in common chronic lung diseases by co-expression networks and drug-target interactions analysis.

Maghsoudloo M, Azimzadeh Jamalkandi S, Najafi A, Masoudi-Nejad A Mol Med. 2020; 26(1):9.

PMID: 31952466 PMC: 6969427. DOI: 10.1186/s10020-019-0135-9.

References
1.
Gelernter J, Kranzler H, Sherva R, Almasy L, Herman A, Koesterer R . Genome-wide association study of nicotine dependence in American populations: identification of novel risk loci in both African-Americans and European-Americans. Biol Psychiatry. 2015; 77(5):493-503. PMC: 4386684. DOI: 10.1016/j.biopsych.2014.08.025. View

2.
Zuo L, Zhang X, Wang F, Li C, Lu L, Ye L . Genome-wide significant association signals in IPO11-HTR1A region specific for alcohol and nicotine codependence. Alcohol Clin Exp Res. 2012; 37(5):730-9. PMC: 3610804. DOI: 10.1111/acer.12032. View

3.
Kolter T, Sandhoff K . Sphingolipid metabolism diseases. Biochim Biophys Acta. 2006; 1758(12):2057-79. DOI: 10.1016/j.bbamem.2006.05.027. View

4.
Augustine R, Seymour A, Campbell R, Grattan D, Brown C . Integrative neuro-humoral regulation of oxytocin neuron activity in pregnancy and lactation. J Neuroendocrinol. 2018; . DOI: 10.1111/jne.12569. View

5.
Hopfer C, Stallings M, Hewitt J . Common genetic and environmental vulnerability for alcohol and tobacco use in a volunteer sample of older female twins. J Stud Alcohol. 2002; 62(6):717-23. DOI: 10.15288/jsa.2001.62.717. View